-
Malaria test adapted to predict treatment side-effects
While most patients who receive the drug of choice (artemisinin artesunate) against malaria recuperate, a small number (less than 5 per cent) develop a serious and often fatal anaemia called post-artesunate delayed haemolysis (PADH) within a month of treatment.
- Categories
- Health Care
-
Fear of a Jobless Planet: Can Entrepreneurship Counter the Coming AI Employment Crisis?
Imagine a future where robots are capable of doing just about everything under the sun, rendering countless professions across practically every industry obsolete. The first part of that dystopian vision has already come to pass. The second part hasn't, but could well be coming. What might be the solution? According to what we learned in July – entrepreneurship month at NB – it might fall on small businesses to answer the challenge.
- Categories
- Social Enterprise, Technology
-
What Common Kitchen Ingredient Can Help Detect Cervical Cancer?
Each year, cervical cancer kills 270,000 women and a third of these deaths occur in just one country: India.
- Categories
- Health Care
- Region
- South Asia
-
As warming brings more malaria, Kenya moves treatment closer to home
With just a medical kit and a mobile phone, health volunteers diagnose villagers with malaria in their own homes.
- Categories
- Environment, Health Care
- Region
- Sub-Saharan Africa
-
The Internet of Living Things
Volunteers around the world and pocket-size genomic sequencers could play an increasing role in protecting global health and ecosystems.
- Categories
- Health Care, Technology
-
The Side Effect Of That New Malaria Drug? American Jobs
The researchers found that between 2007 and 2015, the U.S. government invested $14 billion in global health research and development. And that created 200,000 new American jobs and returned $33 billion to the U.S. economy.
- Categories
- Health Care
-
Opinion: How technology is helping India move toward smart service delivery
In 2015, India launched eVIN, or electronic vaccine intelligence network — a smart, easy-to-use technology aimed at digitizing vaccine stocks in the country. It’s no small ask in a nation with the largest and most ambitious immunization program in the world — aiming to immunize some 156 million women and children each year.
- Categories
- Health Care, Technology
- Region
- South Asia
-
Addressing Eye Care in Emerging Markets with Blended Finance
WHO estimates that 39 million people suffer from blindness, more than half of them due to cataracts, and more than 90 percent of blind people live in the developing world. Cataracts are often curable but the traditional surgery is expensive. Convergence is supporting GlobalVision's plan to build on the affordable eye model that Aravind pioneered in India and establish a network of 60 eye care hospitals in emerging markets over the next 10 years, borrowing techniques from the microfinance sector.
- Categories
- Health Care, Investing, Social Enterprise, Technology
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.